Jefferson National Life Insurance Company, et al., 13926-13931 [E8-5100]
Download as PDF
13926
Federal Register / Vol. 73, No. 51 / Friday, March 14, 2008 / Notices
Generic Survey Plan will be revised to
be an umbrella for all OPM customer
satisfaction surveys used to measure
satisfaction with OPM programs and
services. This Plan satisfies the
requirements of Executive Order 12862
and the guidelines set forth in OMB’s
‘‘Resource Manual for Customer
Surveys’’.
Comments are particularly invited on:
Whether this information is necessary
for the proper performance of functions
of OPM, and whether it will have
practical utility; whether our estimate of
the public burden of this collection of
information is accurate, and based on
valid assumptions and methodology;
and ways in which we can minimize the
burden of the collection of information
on those who are to respond, through
the use of appropriate technological
collection techniques or other forms of
information technology.
The surveys completed will include
web-based (electronic), paper-based,
telephone and focus groups. We
estimate approximately 1,000,000
surveys will be completed annually.
The time estimate varies from 3 minutes
to 2 hours to complete with the average
being 15 minutes. The annual estimated
burden is 250,000 hours.
For copies of this proposal, contact
Mary Beth Smith-Toomey on (202) 606–
2150, Fax (202) 418–3251 or e-mail to:
mbtoomey@opm.gov.
DATES: Comments on this proposal
should be received within 60 calendar
days from the date of this publication.
ADDRESSES: Send or deliver comments
to—Mary Beth Smith-Toomey, OPM
Forms, PRA and Records Officer, Center
for Information Services, U.S. Office of
Personnel Management, 1900 E Street,
NW., Room 5415, Washington, DC
20415.
U.S. Office of Personnel Management.
Howard Weizmann,
Deputy Director.
[FR Doc. E8–5175 Filed 3–13–08; 8:45 am]
BILLING CODE 6325–47–P
SECURITIES AND EXCHANGE
COMMISSION
[Release No. IC–28191; File No. 812–13452]
Jefferson National Life Insurance
Company, et al.
rwilkins on PROD1PC63 with NOTICES
March 10, 2008.
Securities and Exchange
Commission (the ‘‘Commission’’).
ACTION: Notice of application for an
order of approval pursuant to Section
26(c) of the Investment Company Act of
1940, as amended (the ‘‘Act’’), and an
AGENCY:
VerDate Aug<31>2005
19:17 Mar 13, 2008
Jkt 214001
order of exemption pursuant to Section
17(b) of the Act from Section 17(a) of
the Act.
Jefferson National Life
Insurance Company (‘‘JNL’’), Jefferson
National Life Annuity Account C
(‘‘Separate Account C’’), Jefferson
National Life Annuity Account E
(‘‘Separate Account E’’), Jefferson
National Life Annuity Account F
(‘‘Separate Account F’’), Jefferson
National Life Annuity Account G
(‘‘Separate Account G’’), Jefferson
National Life Annuity Account H
(‘‘Separate Account H’’), Jefferson
National Life Annuity Account I
(‘‘Separate Account I’’), Jefferson
National Life Annuity Account J
(‘‘Separate Account J’’), Jefferson
National Life Annuity Account K
(‘‘Separate Account K’’), Conseco
Variable Insurance–Separate Account L
(‘‘Separate Account L’’, and together
with Separate Account C, Separate
Account E, Separate Account F,
Separate Account G, Separate Account
H, Separate Account I, Separate
Account J, and Separate Account K, the
‘‘Separate Accounts’’ and, collectively
with JNL, the ‘‘Applicants’’), and
Northern Lights Variable Trust (‘‘NLVT’’
and collectively with Applicants, the
‘‘Section 17 Applicants’’).
SUMMARY OF APPLICATION: Applicants
seek an order approving the proposed
substitution of shares of the PIMCO
Variable Insurance Trust Money Market
Portfolio (the ‘‘Substitution’’) for shares
of the JNF Money Market Portfolio, a
series of NLVT. Section 17 Applicants
seek an order exempting them from the
provisions of Section 17(a) of the Act to
the extent necessary to permit JNL to
carry out the Substitution.
FILING DATE: The application was
originally filed on November 21, 2007
and amended on March 7, 2008.
HEARING OR NOTIFICATION OF HEARING: An
order granting the application will be
issued unless the Commission orders a
hearing. Interested persons may request
a hearing by writing to the Secretary of
the Commission and serving Applicants
with a copy of the request, personally or
by mail. Hearing requests must be
received by the Commission by 5:30
p.m. on April 2, 2008, and should be
accompanied by proof of service on
Applicants in the form of an affidavit or,
for lawyers, a certificate of service.
Hearing requests should state the nature
of the requester’s interest, the reason for
the request, and the issues contested.
Persons who wish to be notified of a
hearing may request notification by
writing to the Secretary of the
Commission.
APPLICANTS:
PO 00000
Frm 00100
Fmt 4703
Sfmt 4703
Secretary, Securities and
Exchange Commission, 100 F Street,
NE., Washington, DC 20549–1090.
Applicants, 9920 Corporate Campus
Drive, Suite 1000, Louisville, Kentucky
40223.
FOR FURTHER INFORMATION CONTACT:
Michael Kosoff, Staff Attorney, at (202)
551–6754 or Harry Eisenstein, Branch
Chief, Office of Insurance Products,
Division of Investment Management, at
(202) 551–6795.
SUPPLEMENTARY INFORMATION: The
following is a summary of the
application. The complete application
may be obtained for a fee from the
Public Reference Branch of the
Commission, 100 F Street, NE.,
Washington, DC 20549 (202–551–8090).
ADDRESSES:
Applicants’ and Section 17 Applicants’
Representations
1. JNL is a stock life insurance
company originally organized in 1937
under the laws of Texas.
2. Separate Account C was established
in 1980. Separate Account C is
registered under the Act as a unit
investment trust (File No. 811–04819)
and is used to fund variable annuity
contracts issued by JNL. Two variable
annuity contracts funded by Separate
Account C are affected by this
application.
Separate Account E was established
in 1993. Separate Account E is
registered under the Act as a unit
investment trust (File No. 811–08288)
and is used to fund variable annuity
contracts issued by JNL. One variable
annuity contract funded by Separate
Account E is affected by this
application.
Separate Account F was established
in 1997. Separate Account F is
registered under the Act as a unit
investment trust (File No. 811–08483)
and is used to fund variable annuity
contracts issued by JNL. One variable
annuity contract funded by Separate
Account F is affected by this
application.
Separate Account G was established
in 1996. Separate Account G is
registered under the Act as a unit
investment trust (File No. 811–07501)
and is used to fund variable annuity
contracts issued by JNL. Three variable
annuity contracts funded by Separate
Account G are affected by this
application.
Separate Account H was established
in 1999. Separate Account H is
registered under the Act as a unit
investment trust (File No. 811–09693)
and is used to fund variable annuity
contracts issued by JNL. One variable
annuity contract funded by Separate
E:\FR\FM\14MRN1.SGM
14MRN1
Federal Register / Vol. 73, No. 51 / Friday, March 14, 2008 / Notices
Account H is affected by this
application.
Separate Account I was established in
2000. Separate Account I is registered
under the Act as a unit investment trust
(File No. 811–10213) and is used to
fund variable annuity contracts issued
by JNL. One variable annuity contract
funded by Separate Account I is affected
by this application.
Separate Account J was established in
2003. Separate Account J is registered
under the Act as a unit investment trust
(File No. 811–21498) and is used to
fund variable annuity contracts issued
by JNL. One variable annuity contract
funded by Separate Account J is affected
by this application.
Separate Account K was established
in 2003. Separate Account K is
registered under the Act as a unit
investment trust (File No. 811–21500)
and is used to fund variable annuity
contracts issued by JNL. One variable
annuity contract funded by Separate
Account K is affected by this
application.
Separate Account L was established
in 2000. Separate Account L is
registered under the Act as a unit
investment trust (File No. 811–10271)
and is used to fund variable universal
life contracts issued by JNL. One
variable universal life contract funded
by Separate Account L is affected by
this application (all eleven variable
annuity contracts and the one variable
universal life contract affected by this
application are hereinafter collectively
referred to as the ‘‘Contracts’’).
3. NLVT was organized in Delaware
as a statutory trust on November 2, 2005
and is registered under the Act as an
open-end management investment
company.
4. Pacific Investment Management
Company, LLC (‘‘PIMCO’’) is the
investment adviser for the PIMCO
Variable Insurance Trust Money Market
Portfolio (the ‘‘Replaced Fund’’). PIMCO
and the Replaced Fund are not affiliated
with JNL. JNF Advisors, Inc. (‘‘JNF
Advisor’’) is a recently formed
investment adviser under common
control with JNL. JNF Advisor will serve
as investment adviser to the JNF Money
Market Portfolio (the ‘‘Replacement
Fund’’). A I M Advisors, Inc. (‘‘AIM’’)
will be sub-adviser for the Replacement
Fund. AIM is not affiliated with JNL.
There are no corporate affiliations
among the investment advisers.
5. Purchase payments under the
Contracts may be allocated to one or
more sub-accounts of the Separate
Accounts (the ‘‘Sub-Accounts’’).
Income, gains and losses, whether or not
realized, from assets allocated to the
Separate Accounts are credited to or
charged against the Separate Accounts
without regard to other income, gains or
losses of JNL. The assets maintained in
the Separate Accounts will not be
charged with any liabilities arising out
of any other business conducted by JNL.
Nevertheless, all obligations arising
under the Contracts, including the
commitment to make annuity payments
or death benefit payments, are general
corporate obligations of JNL.
Accordingly, all of the assets of JNL are
available to meet its obligations under
the Contracts.
6. The Contracts permit allocations of
account value to available Sub-Accounts
that invest in specific investment
13927
portfolios of underlying registered
investment companies (a ‘‘Fund’’ and,
collectively, the ‘‘Mutual Funds’’). The
Mutual Funds are registered under the
Act as open-end management
investment companies.
7. The Contracts permit transfers of
accumulation value from one SubAccount to another Sub-Account at any
time subject to certain restrictions. No
sales charge applies to such a transfer of
accumulation value among SubAccounts. A transaction fee is imposed
on purchases or redemptions involving
Sub-Accounts (‘‘Transaction Fee SubAccounts’’) which invest in certain
Funds.1 None of the Transaction Fee
Sub-Accounts hold shares of a money
market fund.
8. The Contracts reserve the right,
upon notice to contract owners (the
‘‘Contract Owners’’), to substitute shares
of another mutual fund for shares of a
Fund held by a Sub-Account.
9. After the Substitution, the
investment objective and policies of the
Replacement Fund will be substantially
similar to the investment objective and
policies of the Replaced Fund.
10. JNF Advisor will serve as the
investment adviser for the Replacement
Fund. However, the management of the
Replacement Fund will be sub-advised
by AIM. For the Replaced Fund and the
Replacement Fund, the investment
objectives, principal risks, investment
adviser/sub-adviser, and fee structure
are shown in the tables that follow. The
tables also show the Replaced Fund’s
expenses for the fiscal year ending in
2007 and assets as of December 31,
2007.
11. Substitution 1
Replaced fund
Fund Name .........................................................
Investment Objective ..........................................
Strategy ..............................................................
rwilkins on PROD1PC63 with NOTICES
Principal Risks ....................................................
Replacement fund
PIMCO Variable Insurance Trust Money Market Portfolio.
Seeks maximum current income, consistent
with preservation of capital and daily liquidity.
Invests at least 95% of its total assets in a diversified portfolio of money market securities that are in the highest rating category
for short-term obligations. May invest up to
5% of its total assets in money market securities in the second highest rating category. Will only invest in U.S. dollar denominated securities maturing in 397 days
or less. Dollar-weighted average portfolio
maturity will not exceed 90 days.
• Market Risk ...........................................
• Interest Rate Risk .................................
JNF Money Market Portfolio; subadvised by
AIM
Seeks as high a level of current income as is
consistent with preservation of capital and
daily liquidity.
Invests at least 95% of its total assets in a diversified portfolio of money market securities that are in the highest rating category
for short-term obligations. May invest up to
5% of its total assets in money market securities in the second highest rating category. Will only invest in U.S. dollar denominated securities maturing in 397 days
or less. Dollar-weighted average portfolio
maturity will not exceed 90 days
• Market Risk.
• Interest Rates and Bond Maturities
Risk.
• Municipal Bond Risk.
• U.S. Government Obligations Risk.
• Inflation—Index Securities Risk.
• Issuer Risk ............................................
• Management Risk .................................
• Inflation—Indexed Securities Risk ........
1 The Monument Adviser contract (File No. 333–
124048) is the only contract covered by this
application that imposes the transaction fee.
VerDate Aug<31>2005
19:17 Mar 13, 2008
Jkt 214001
PO 00000
Frm 00101
Fmt 4703
Sfmt 4703
E:\FR\FM\14MRN1.SGM
14MRN1
13928
Federal Register / Vol. 73, No. 51 / Friday, March 14, 2008 / Notices
Replaced fund
Significant Principal Risk Disparities? ................
Adviser/Subadviser .............................................
Fund Asset Level as of 9/30/07 .........................
Advisory Fee ......................................................
Advisory Fee Schedule ......................................
Service Fee ........................................................
12b–1 Fee ..........................................................
Other Expenses ..................................................
Total Annual Operating Expenses .....................
Fee Reduction ....................................................
Net Total Annual Expenses ...............................
Replacement fund
• Foreign (Non-U.S.) Investment Risk .....
• Foreign Securities Risk.
• Credit Risk .............................................
• Credit Risk.
None
PIMCO ............................................................. JNF Advisor/ AIM.
$376,000,000 (a) ............................................... $0
0.15% ............................................................... 0.15%
0.15% (b) ........................................................... 0.15% (b)
0.15% ............................................................... 0
0 ....................................................................... 0 (c)
0.20% ............................................................... 0.51% (d)
0.50% ............................................................... 0.66%
N/A ................................................................... 0.16% (e)
0.50% ............................................................... 0.50%
(a) As
of December 31, 2007, approximately 32% of the Replaced Fund’s assets would be transferred to the Replacement Fund.
advisory fee schedule does not contain breakpoints.
affirmative vote of shareholders would be required to approve a Rule 12b–1 plan for the Replacement Fund.
(d) Other fees are based on estimated amounts for the Portfolio’s current fiscal year.
(e) JNF Advisor has contractually agreed to waive its investment advisory fees and/or reimburse the Money Market Portfolio to the extent that
the ratio of expenses (excluding brokerage fees and commissions, acquired fund fees and expenses, borrowing costs (such as interest and dividend expense on securities sold short), taxes and extraordinary expenses) to net assets on an annual basis exceeds 0.50% for the Money Market Portfolio. JNF Advisor may discontinue the contractual limits at any time after April 30, 2009, subject to the condition in this Application relating to the maximum total operating expenses for the Replacement Fund for the 24 months following the Substitution.
(b) The
rwilkins on PROD1PC63 with NOTICES
(c) An
The Applicants believe that the
Replacement Fund is an appropriate
substitute for the Replaced Fund
because the investment objective and
policies of the Replacement Fund are
substantially similar to those of the
Replaced Fund. Because the
Substitution involves replacing one
money market fund with another money
market fund, the Substitution will not
result in a reduced number or a change
in the investment characteristics of the
investment options offered under the
Contracts.
12. The Substitution will take place at
the Funds’ relative net asset values
determined on the date of the
Substitution in accordance with Section
22 of the Act and Rule 22c–1 thereunder
with no change in the amount of any
Contract Owner’s account value or
death benefit or in the dollar value of
his or her investment in any of the SubAccounts. Accordingly, there will be no
financial impact on any Contract
Owner.
13. The Substitution may be effected
by having each of the Sub-Accounts that
invests in the Replaced Fund redeem its
shares at the net asset value calculated
on the date of the Substitution and
purchase shares of the Replacement
Fund at the net asset value calculated
on the same date.
14. In the alternative, should the
Replaced Fund determine that a cash
redemption would adversely affect its
shareholders, it may redeem the interest
‘‘in-kind.’’ In that case, the Substitution
will be effected by the Sub-Account
contributing all the securities it receives
from the Replaced Fund for an amount
of Replacement Fund shares equal to the
fair market value of the securities
contributed. All in-kind redemptions
VerDate Aug<31>2005
19:17 Mar 13, 2008
Jkt 214001
from the Replaced Fund of which any
of the Applicants is an affiliated person
will be effected in accordance with the
conditions set forth in the Commission’s
no-action letter issued to Signature
Financial Group, Inc. (available Dec. 28,
1999).
15. The Substitution will be described
in a supplement to the prospectuses for
the Contracts (‘‘Supplement’’) filed with
the Commission and mailed to Contract
Owners. The Supplement will provide
Contract Owners with notice of the
Substitution and describe the reasons
for engaging in the Substitution. The
Supplement also will inform Contract
Owners with assets allocated to a SubAccount investing in the Replaced Fund
that the Replaced Fund will not be an
available investment option after the
date of the Substitution and that
Contract Owners will have the
opportunity to reallocate account value
on one day to one or more SubAccounts:
• Prior to the Substitution, from the
Sub-Accounts investing in the Replaced
Fund, and
• For 30 days after the Substitution,
from the Sub-Accounts investing in the
Replacement Fund to Sub-Accounts
investing in another Fund available
under the respective Contracts,
Without diminishing the number of free
transfers that may be made in a given
contract year and without the
imposition of any transfer charge or
limitation, other than the transaction fee
applicable to certain Sub-Accounts and
any applicable limitations in place to
deter potentially harmful excessive
trading.2
2 There are five Transaction Fee Sub-Accounts
which are available only under one annuity
PO 00000
Frm 00102
Fmt 4703
Sfmt 4703
16. The prospectuses for the Contracts
will contain the substance of the
information contained in the
Supplement concerning the
Substitution. Each Contract Owner will
be provided with a prospectus for the
Replacement Fund before the
Substitution, unless the Replacement
Fund becomes effective
contemporaneously with the
Substitutions, in which case a
prospectus will be sent to affected
Contract Owners with the written
confirmation. Within five days after the
Substitution, JNL will send affected
Contract Owners written confirmation
that the Substitution has occurred and
notice that Contract Owners will have
the opportunity to reallocate account
value for 30 days after the Substitution,
from the Sub-Accounts investing in the
Replacement Fund to Sub-Accounts
investing in another Fund available
under the respective Contracts, without
diminishing the number of free transfers
that may be made in a given contract
year and without the imposition of any
transfer charge or limitation, other than
the transaction fee applicable to certain
Sub-Accounts and any applicable
limitations in place to deter potentially
harmful excessive trading.
contract (File No. 333–124048) which offers 160 nofee Sub-Accounts. The Transaction Fee SubAccounts hold shares of the following Nationwide
VIT Index Funds: S&P 500; Small Cap; Mid Cap;
International and Bond. These funds have
investment characteristics which are completely
unlike those of the Pimco Variable Insurance Trust
Money Market Portfolio which is being replaced in
the Substitution. In light of the foregoing
Applicants do not believe there is any investor
protection basis not to allow the substituted
Contract Owners to bear a charge applicable to all
other Contract Owners seeking to invest in a
Transaction Fee Sub-Account.
E:\FR\FM\14MRN1.SGM
14MRN1
Federal Register / Vol. 73, No. 51 / Friday, March 14, 2008 / Notices
rwilkins on PROD1PC63 with NOTICES
17. JNL will pay all direct and
indirect expenses and transaction costs
of the Substitution, including all legal,
accounting and brokerage expenses
relating to the Substitution. No costs
will be borne by Contract Owners.
Affected Contract Owners will not incur
any fees or charges as a result of the
Substitution, nor will their rights or the
obligations of the Applicants under the
Contracts be altered in any way. The
Substitution will not cause the fees and
charges under the Contracts currently
being paid by Contract Owners to be
greater after the Substitution than before
the Substitution. The Substitution will
have no adverse tax consequences to
Contract Owners and will in no way
alter the tax benefits to Contract
Owners.
18. Applicants believe that their
request satisfies the standards for relief
pursuant to Section 26(c) of the Act, as
set forth below, because the affected
Contract Owners will have:
(1) Account values allocated to a SubAccount invested in the Replacement
Fund with an investment objective and
policies substantially similar to the
investment objective and policies of the
Replaced Fund; and
(2) The Replacement Fund whose
current total annual expenses will be no
higher than that of the Replaced Fund
for its 2007 fiscal year because, as
described below, JNL has agreed to, for
a period of 24 months following the
Substitutions, limit the total net
expenses of the Replacement Fund to
those of the Replaced Fund for the 2007
fiscal year. At the end of the 24 month
period it is possible that the expenses of
the Replacement Fund may be higher.
Applicants’ and Section 17 Applicants’
Legal Analysis
1. The Applicants represent that
Section 26(c) of the Act makes it
unlawful for any depositor or trustee of
a registered unit investment trust
holding the security of a single issuer to
substitute another security for such
security unless the Commission
approves the substitution. The
Commission will approve such a
substitution if the evidence establishes
that it is consistent with the protection
of investors and the purposes fairly
intended by the policy and provisions of
the Act.
2. The Applicants note that the
purpose of Section 26(c) is to protect the
expectation of investors in a unit
investment trust that the unit
investment trust will accumulate shares
of a particular issuer by preventing
unscrutinized substitutions that might,
in effect, force shareholders dissatisfied
with the substituted security to redeem
VerDate Aug<31>2005
19:17 Mar 13, 2008
Jkt 214001
their shares, thereby possibly incurring
either a loss of the sales load deducted
from initial premium payments, an
additional sales load upon reinvestment
of the redemption proceeds, or both.
Moreover, in the insurance product
context, a Contract Owner forced to
redeem may suffer adverse tax
consequences. Section 26(c) affords this
protection to investors by preventing a
depositor or trustee of a unit investment
trust that holds shares of one issuer
from substituting for those shares the
shares of another issuer, unless the
Commission approves that substitution.
3. The Applicants assert that the
purposes, terms and conditions of the
Substitution are consistent with the
principles and purposes of Section 26(c)
and do not entail any of the abuses that
Section 26(c) is designed to prevent.
Applicants have reserved the right to
make such a substitution under the
Contracts and this reserved right is
disclosed in the prospectus for the
Contracts.
4. The Applicants submit that the
investment objectives and policies of
the Replacement Fund are sufficiently
similar to those of the Replaced Fund
that Contract Owners will have
continuity in investment expectations.
Accordingly, the Replacement Fund is
an appropriate investment vehicle for
those Contract Owners who have
account values allocated to the Replaced
Fund.
5. The Applicants represent that for
the 24-month period following the date
of the Substitution, JNL agrees to limit
the total operating expenses of the
Replacement Fund (taking into account
any expense waiver or reimbursement)
on an annualized basis to the net
expense level of the Replaced Fund for
the 2007 fiscal year. In addition, for 24
months following the Substitution, JNL
will not increase asset-based fees or
charges for Contracts outstanding on the
day of the Substitution. JNL represents
that the Substitution and the selection
of the Replacement Fund were not
motivated by any financial
consideration paid or to be paid by the
Replacement Fund, its adviser. its subadviser or underwriters, or their
respective affiliates.3
3 In this regard, JNL has been receiving .30%
annually in ‘‘revenue sharing’’ with respect to
investments by its separate accounts in the
Replaced Fund and expects that it will receive that
same percentage amount from the Replacement
Fund. With respect to the Replaced Fund, JNL
receives .15% pursuant to the Replaced Fund’s
Administrative Services Plan and .15% from the
Replaced Fund’s investment adviser for nonmarketing services rendered to current and
prospective Contract Owners. With respect to the
Replacement Fund, JNL expects to receive from the
PO 00000
Frm 00103
Fmt 4703
Sfmt 4703
13929
6. The Applicants assert that the
Substitution will not result in the type
of costly forced redemption that Section
26(c) was intended to guard against and,
for the following reasons, is consistent
with the protection of investors and the
purposes fairly intended by the Act:
(1) The Replacement Fund is an
appropriate fund to which to move
Contract Owners with account values
allocated to the Replaced Fund because
the new fund has substantially similar
investment objectives and policies.
(2) The costs of the Substitution,
including any brokerage costs, will be
borne by JNL and will not be borne by
Contract Owners. No charges will be
assessed to effect the Substitution.
(3) The Substitution will be at the net
asset value of the shares without the
imposition of any transfer or similar
charge and with no change in the
amount of any Contract Owner’s
account value.
(4) The Substitution will not cause the
fees and charges under the Contracts
currently being paid by Contract
Owners to be greater after the
Substitution than before the
Substitution and will result in Contract
Owners’ account values being moved to
a Fund with the same or lower current
total annual expenses.
(5) All Contract Owners will be given
notice of the Substitution prior to the
Substitution and will have an
opportunity before, and for 30 days
after, the Substitution to reallocate
account value among other available
Sub-Accounts without diminishing the
number of free transfers that may be
made in a given contract year and
without the imposition of any transfer
charge or limitation, other than the
transaction fee applicable to certain
Sub-Accounts and any applicable
limitations in place to deter potentially
harmful excessive trading or limitation
on the number of transfers to or from the
fixed accounts available with the
variable annuity contracts.
(6) Within five days after the
Substitution, JNL will send to its
affected Contract Owners written
confirmation that the Substitution has
occurred.
(7) The Substitution will in no way
alter the insurance benefits to Contract
Owners or the contractual obligations of
JNL.
(8) The Substitution will have no
adverse tax consequences to Contract
Owners and will in no way alter the tax
benefits to Contract Owners.
(9) The Replacement Fund will not
rely on any ‘‘manager of managers’’
Replacement Fund .30% for administrative
services.
E:\FR\FM\14MRN1.SGM
14MRN1
rwilkins on PROD1PC63 with NOTICES
13930
Federal Register / Vol. 73, No. 51 / Friday, March 14, 2008 / Notices
exemptive relief unless such action is
approved by a majority of the
Replacement Fund’s shareholders at a
meeting whose record date is after the
Substitution has been effected.
7. The Section 17 Applicants request
an order under Section 17(b) exempting
them from the provisions of Section
17(a) to the extent necessary to permit
JNL to carry out the proposed
substitution. Section 17(a)(1) of the Act,
in relevant part, prohibits any affiliated
person of a registered investment
company, or any affiliated person of
such person, acting as principal, from
knowingly selling any security or other
property to that company. Section
17(a)(2) of the Act generally prohibits
the persons described above, acting as
principal, from knowingly purchasing
any security or other property from the
registered company.
8. JNL, as depositor of the Separate
Accounts, is an affiliate of the Separate
Accounts and also JNF Advisor, which
serves as investment adviser for the
affected NLVT series. As such, JNF
Advisor could be deemed to control the
affected NLVT series and be an affiliate
of the affected NLVT series. Assuming,
for this or other reasons, that an affected
NLVT series is an affiliate of an affiliate
of JNL, to the extent the Separate
Accounts each use assets received inkind to purchase Replacement Fund
Shares, the substitutions would involve
one or more purchases or sales of
securities or property between persons
who are affiliates of affiliates.
Accordingly, the Section 17 Applicants
are seeking relief, to the extent
necessary, from Section 17(a) for the inkind purchases and sales of
Replacement Fund Shares.
9. Section 17(b) of the Act provides
that the Commission may, upon
application, grant an order exempting
any transaction from the prohibitions of
Section 17(a) if the evidence establishes
that:
(1) The terms of the proposed
transaction, including the consideration
to be paid or received, are reasonable
and fair and do not involve
overreaching on the part of any person
concerned;
(2) The proposed transaction is
consistent with the policy of each
registered investment company
concerned, as recited in its registration
statement and records filed under the
Act; and
(3) The proposed transaction is
consistent with the general purposes of
the Act.
10. The Section 17 Applicants submit
that, for all the reasons set forth in
paragraphs 3–6 immediately above, the
terms of the proposed in-kind purchases
VerDate Aug<31>2005
19:17 Mar 13, 2008
Jkt 214001
of shares of the Replacement Fund by
the Separate Accounts, including the
consideration to be paid and received,
as described in this Application, are
reasonable and fair and do not involve
overreaching on the part of any person
concerned. The Section 17 Applicants
also submit that the proposed in-kind
purchases by the Separate Accounts are
consistent with the policies of JNL and
the affected NLVT series. Finally, the
Section 17 Applicants submit that the
proposed substitutions are consistent
with the general purposes of the Act.
11. The Section 17 Applicants assert
that, to the extent the Separate
Account’s in-kind purchases of
Replacement Fund shares are deemed to
involve principal transactions between
entities which are affiliates of affiliates,
the procedures described below should
be sufficient to assure that the terms of
the proposed transactions are reasonable
and fair to all participants. The Section
17 Applicants maintain that the terms of
the proposed in-kind purchase
transactions, including the
consideration to be paid and received by
each Fund involved, are reasonable, fair
and do not involve overreaching. In
addition, although not applicable, the
in-kind transactions will conform with
all except one of the conditions
enumerated in Rule 17a–7. The
proposed transactions will take place at
relative net asset value in conformity
with the requirements of Section 22(c)
of the Act and Rule 22c–1 thereunder
with no change in the amount of any
Contract Owner’s account value or
death benefit or in the dollar value of
his or her investment in any SubAccount. Contract Owners will not
suffer any adverse tax consequences as
a result of the substitution. The fees and
charges under the Contracts will not
increase because of the substitution.
Even though they may not rely on Rule
17a–7, the Section 17 Applicants
believe that the Rule’s conditions
outline the type of safeguards that result
in transactions that are fair and
reasonable to registered investment
company participants and preclude
overreaching.
12. The Section 17 Applicants will
carry out the proposed in-kind
purchases in conformity with all of the
conditions of Rule 17a–7 and the
Replacement Fund’s procedures
thereunder, except that the
consideration paid for the securities
being purchased or sold may not be
entirely cash. Nevertheless, the
circumstances surrounding the
proposed substitution will be such as to
offer the same degree of protection to
the Replacement Fund from
overreaching that Rule 17a–7 provides
PO 00000
Frm 00104
Fmt 4703
Sfmt 4703
to them generally in connection with
their purchase and sale of securities
under that Rule in the ordinary course
of their business. In particular, JNL (or
any of their affiliates) cannot effect the
proposed transaction at a price that is
disadvantageous to the Replacement
Fund. Although the transaction may not
be entirely for cash, it will be effected
based upon (1) the independent market
price of the portfolio securities valued
as specified in paragraph (b) of Rule
17a–7, and (2) the net asset value per
share of the Fund valued in accordance
with the procedures disclosed in its
registration statement and as required
by Rule 22c–1 under the Act. No
brokerage commission, fee, or other
remuneration will be paid to any party
in connection with the proposed in-kind
transaction.
13. The Section 17 Applicants assert
that the sale of shares of the
Replacement Fund for investment
securities, as contemplated by the
proposed in-kind transaction, is
consistent with the investment policy
and restrictions of the Replacement
Fund because (1) the shares are sold at
their net asset value, and (2) the
portfolio securities are of the type and
quality that the Replacement Fund
would each have acquired with the
proceeds from share sales had the shares
been sold for cash. To assure that the
second of these conditions is met, the
sub-adviser will examine the portfolio
securities being offered to the
Replacement Fund and accept only
those securities as consideration for
shares that it would have acquired for
such fund in a cash transaction.
14. The Section 17 Applicants submit
that the proposed in-kind transactions
are consistent with the general purposes
of the Act as stated in the Findings and
Declaration of Policy in Section 1 of the
Act. The proposed transactions do not
present any of the conditions or abuses
that the Act was designed to prevent. In
particular, Sections 1(b)(2) and (3) of the
Act state, among other things, that the
national public interest and the interest
of investors are adversely affected
‘‘when investment companies are
organized, operated, managed, or their
portfolio securities are selected in the
interest of directors, officers, investment
advisers, depositors, or other affiliated
persons thereof, or in the interests of
other investment companies or persons
engaged in other lines of business,
rather than in the interest of all classes
of such companies’ security holders;
* * * when investment companies
issue securities containing inequitable
or discriminatory provisions, or fail to
protect the preferences and privileges of
the holders of their outstanding
E:\FR\FM\14MRN1.SGM
14MRN1
Federal Register / Vol. 73, No. 51 / Friday, March 14, 2008 / Notices
securities * * *.’’ For all the reasons
stated in Sections V.B. and VI of the
Application, the abuses described in
Sections l(b)(2) and (3) of the Act will
not occur in connection with the
proposed in-kind purchases.
15. The Section 17 Applicants note
that the Commission has previously
granted exemptions from Section 17(a)
in circumstances substantially similar in
all material respects to those presented
in this Application to applicants
affiliated with an open-end management
investment company that proposed to
purchase shares issued by the company
with investment securities of the type
that the company might otherwise have
purchased for its portfolio. In these
cases, the Commission issued an order
pursuant to Section 17(b) of the Act
where the expense of liquidating such
investment securities and using the cash
proceeds to purchase shares of the
investment company would have
reduced the value of investors’ ultimate
investment in such shares.
Conclusion
For the reasons and upon the facts set
forth above, the Applicants and the
Section 17 Applicants believe that the
requested order meets the standards set
forth in Section 26(c) and Section 17(b),
respectively, and should, therefore, be
granted.
For the Commission, by the Division of
Investment Management, under delegated
authority.
Florence E. Harmon,
Deputy Secretary.
[FR Doc. E8–5100 Filed 3–13–08; 8:45 am]
BILLING CODE 8011–01–P
SECURITIES AND EXCHANGE
COMMISSION
[Release No. IC–28190; File No. 812–13439]
MetLife Insurance Company of
Connecticut, et al.
March 10, 2008.
Securities and Exchange
Commission (‘‘Commission’’).
ACTION: Notice of application for an
order pursuant to Section 26(c) of the
Investment Company Act of 1940 (the
‘‘Act’’) approving certain substitutions
of securities and an order of exemption
pursuant to Section 17(b) of the Act
from Section 17(a) of the Act.
rwilkins on PROD1PC63 with NOTICES
AGENCY:
MetLife Insurance
Company of Connecticut (‘‘MetLife of
CT’’), MetLife of CT Separate Account
Five for Variable Annuities (‘‘Separate
Account Five’’), MetLife of CT Separate
Account Seven for Variable Annuities
APPLICANTS:
VerDate Aug<31>2005
19:17 Mar 13, 2008
Jkt 214001
(‘‘Separate Account Seven’’), MetLife of
CT Separate Account Nine for Variable
Annuities (‘‘Separate Account Nine’’),
MetLife of CT Separate Account Eleven
for Variable Annuities (‘‘Separate
Account Eleven’’), MetLife of CT
Separate Account Thirteen for Variable
Annuities (‘‘Separate Account
Thirteen’’), MetLife of CT Fund U for
Variable Annuities (‘‘Fund U’’), MetLife
of CT Separate Account PF for Variable
Annuities (‘‘Separate Account PF’’),
MetLife of CT Separate Account TM for
Variable Annuities (‘‘Separate Account
TM’’), MetLife of CT Fund ABD for
Variable Annuities (‘‘Fund ABD’’),
MetLife of CT Fund BD for Variable
Annuities (‘‘Fund BD’’), MetLife of CT
Separate Account QP for Variable
Annuities (‘‘Separate Account QP’’),
MetLife of CT Separate Account QPN
for Variable Annuities (‘‘Separate
Account QPN’’), MetLife of CT Fund BD
III for Variable Annuities (‘‘Fund BD
III’’), MetLife Insurance Company of CT
Variable Annuity Separate Account
2002 (‘‘Separate Account 2002’’),
MetLife of CT Separate Account
CPPVUL I (‘‘Separate Account CPPVUL
I’’), MetLife of CT Fund UL III for
Variable Life Insurance (‘‘Fund UL III’’),
MetLife of CT Fund UL for Variable Life
Insurance (‘‘Fund UL’’), MetLife of CT
Separate Account Six for Variable
Annuities (‘‘Separate Account Six’’),
MetLife of CT Separate Account Eight
for Variable Annuities (‘‘Separate
Account Eight’’), MetLife of CT Separate
Account Ten for Variable Annuities
(‘‘Separate Account Ten’’), MetLife of
CT Separate Account Twelve for
Variable Annuities (‘‘Separate Account
Twelve’’), MetLife of CT Separate
Account Fourteen for Variable
Annuities (‘‘Separate Account
Fourteen’’), MetLife of CT Separate
Account PF II for Variable Annuities
(‘‘Separate Account PF II’’), MetLife of
CT Separate Account TM II for Variable
Annuities (‘‘Separate Account TM II’’),
MetLife of CT Fund ABD II for Variable
Annuities (‘‘Fund ABD II’’), MetLife of
CT Fund BD II for Variable Annuities
(‘‘Fund BD II’’), MetLife of CT Fund BD
IV for Variable Annuities (‘‘Fund BD
IV’’), MetLife Life and Annuity
Company of CT Variable Annuity
Separate Account 2002 (‘‘MetLife LAN
Separate Account 2002’’), MetLife of CT
Fund UL II for Variable Life Insurance
(‘‘Fund UL II’’), MetLife Investors
Insurance Company (‘‘MetLife
Investors’’), MetLife Investors Variable
Annuity Account One (‘‘VA Account
One’’), MetLife Investors Variable
Annuity Account Five (‘‘VA Account
Five’’), MetLife Investors Variable Life
Account One (‘‘VL Account One’’),
PO 00000
Frm 00105
Fmt 4703
Sfmt 4703
13931
MetLife Investors Variable Life Account
Five (‘‘VL Account Five’’), MetLife
Investors Variable Life Account Eight
(‘‘VL Account Eight’’), First MetLife
Investors Insurance Company (‘‘First
MetLife Investors’’), First MetLife
Investors Variable Annuity Account
One (‘‘First VA Account One’’), MetLife
Investors USA Insurance Company
(‘‘MetLife Investors USA’’), MetLife
Investors USA Separate Account A
(‘‘Separate Account A’’), Metropolitan
Life Insurance Company (‘‘MetLife’’),
Metropolitan Life Separate Account E
(‘‘Separate Account E’’), Metropolitan
Life Separate Account F (‘‘Separate
Account F’’), Metropolitan Life Separate
Account DCVL (‘‘Separate Account
DCVL’’), Metropolitan Life Separate
Account UL (‘‘Separate Account UL’’),
Metropolitan Life Variable Annuity
Separate Account I (formerly First
Citicorp Life Variable Annuity Separate
Account) (‘‘Separate Account I’’),
Metropolitan Life Variable Annuity
Separate Account II (formerly Citicorp
Life Variable Annuity Separate
Account) (‘‘Separate Account II’’),
Metropolitan Life Separate Account 18S
(formerly Security Equity Separate
Account 18) (‘‘Separate Account 18S’’),
Metropolitan Life Separate Account 13S
(formerly Security Equity Separate
Account 13) (‘‘Separate Account 13S’’),
Metropolitan Life Separate Account 37S
(formerly Security Equity Separate
Account 37) (‘‘Separate Account 37S’’),
Security Equity Separate Account
Twenty Six (‘‘SE Separate Account
Twenty Six’’), The New England
Variable Account (‘‘NEVA’’), New
England Life Insurance Company (‘‘New
England’’), New England Variable Life
Separate Account (‘‘NEVL Separate
Account’’), New England Variable Life
Separate Account Four (‘‘NEVL Separate
Account Four’’), New England Variable
Life Separate Account Five (‘‘NEVL
Separate Account Five’’), General
American Life Insurance Company
(‘‘General American’’) (together with
MetLife of CT, MetLife Investors, First
MetLife Investors, MetLife Investors
USA, MetLife, New England and
General American, the ‘‘Insurance
Companies’’), General American
Separate Account Two (‘‘GA Separate
Account Two’’), General American
Separate Account Seven (‘‘GA Separate
Account Seven’’), General American
Separate Account Eleven (‘‘GA Separate
Account Eleven’’), General American
Separate Account Twenty Eight (‘‘GA
Separate Account Twenty Eight’’),
General American Separate Account
Thirty-Three (‘‘Separate Account ThirtyThree’’), General American Separate
Account Fifty-Eight (‘‘GA Separate
E:\FR\FM\14MRN1.SGM
14MRN1
Agencies
[Federal Register Volume 73, Number 51 (Friday, March 14, 2008)]
[Notices]
[Pages 13926-13931]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-5100]
=======================================================================
-----------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
[Release No. IC-28191; File No. 812-13452]
Jefferson National Life Insurance Company, et al.
March 10, 2008.
AGENCY: Securities and Exchange Commission (the ``Commission'').
ACTION: Notice of application for an order of approval pursuant to
Section 26(c) of the Investment Company Act of 1940, as amended (the
``Act''), and an order of exemption pursuant to Section 17(b) of the
Act from Section 17(a) of the Act.
-----------------------------------------------------------------------
Applicants: Jefferson National Life Insurance Company (``JNL''),
Jefferson National Life Annuity Account C (``Separate Account C''),
Jefferson National Life Annuity Account E (``Separate Account E''),
Jefferson National Life Annuity Account F (``Separate Account F''),
Jefferson National Life Annuity Account G (``Separate Account G''),
Jefferson National Life Annuity Account H (``Separate Account H''),
Jefferson National Life Annuity Account I (``Separate Account I''),
Jefferson National Life Annuity Account J (``Separate Account J''),
Jefferson National Life Annuity Account K (``Separate Account K''),
Conseco Variable Insurance-Separate Account L (``Separate Account L'',
and together with Separate Account C, Separate Account E, Separate
Account F, Separate Account G, Separate Account H, Separate Account I,
Separate Account J, and Separate Account K, the ``Separate Accounts''
and, collectively with JNL, the ``Applicants''), and Northern Lights
Variable Trust (``NLVT'' and collectively with Applicants, the
``Section 17 Applicants'').
Summary of Application: Applicants seek an order approving the proposed
substitution of shares of the PIMCO Variable Insurance Trust Money
Market Portfolio (the ``Substitution'') for shares of the JNF Money
Market Portfolio, a series of NLVT. Section 17 Applicants seek an order
exempting them from the provisions of Section 17(a) of the Act to the
extent necessary to permit JNL to carry out the Substitution.
Filing Date: The application was originally filed on November 21, 2007
and amended on March 7, 2008.
Hearing or Notification of Hearing: An order granting the application
will be issued unless the Commission orders a hearing. Interested
persons may request a hearing by writing to the Secretary of the
Commission and serving Applicants with a copy of the request,
personally or by mail. Hearing requests must be received by the
Commission by 5:30 p.m. on April 2, 2008, and should be accompanied by
proof of service on Applicants in the form of an affidavit or, for
lawyers, a certificate of service. Hearing requests should state the
nature of the requester's interest, the reason for the request, and the
issues contested. Persons who wish to be notified of a hearing may
request notification by writing to the Secretary of the Commission.
ADDRESSES: Secretary, Securities and Exchange Commission, 100 F Street,
NE., Washington, DC 20549-1090. Applicants, 9920 Corporate Campus
Drive, Suite 1000, Louisville, Kentucky 40223.
FOR FURTHER INFORMATION CONTACT: Michael Kosoff, Staff Attorney, at
(202) 551-6754 or Harry Eisenstein, Branch Chief, Office of Insurance
Products, Division of Investment Management, at (202) 551-6795.
SUPPLEMENTARY INFORMATION: The following is a summary of the
application. The complete application may be obtained for a fee from
the Public Reference Branch of the Commission, 100 F Street, NE.,
Washington, DC 20549 (202-551-8090).
Applicants' and Section 17 Applicants' Representations
1. JNL is a stock life insurance company originally organized in
1937 under the laws of Texas.
2. Separate Account C was established in 1980. Separate Account C
is registered under the Act as a unit investment trust (File No. 811-
04819) and is used to fund variable annuity contracts issued by JNL.
Two variable annuity contracts funded by Separate Account C are
affected by this application.
Separate Account E was established in 1993. Separate Account E is
registered under the Act as a unit investment trust (File No. 811-
08288) and is used to fund variable annuity contracts issued by JNL.
One variable annuity contract funded by Separate Account E is affected
by this application.
Separate Account F was established in 1997. Separate Account F is
registered under the Act as a unit investment trust (File No. 811-
08483) and is used to fund variable annuity contracts issued by JNL.
One variable annuity contract funded by Separate Account F is affected
by this application.
Separate Account G was established in 1996. Separate Account G is
registered under the Act as a unit investment trust (File No. 811-
07501) and is used to fund variable annuity contracts issued by JNL.
Three variable annuity contracts funded by Separate Account G are
affected by this application.
Separate Account H was established in 1999. Separate Account H is
registered under the Act as a unit investment trust (File No. 811-
09693) and is used to fund variable annuity contracts issued by JNL.
One variable annuity contract funded by Separate
[[Page 13927]]
Account H is affected by this application.
Separate Account I was established in 2000. Separate Account I is
registered under the Act as a unit investment trust (File No. 811-
10213) and is used to fund variable annuity contracts issued by JNL.
One variable annuity contract funded by Separate Account I is affected
by this application.
Separate Account J was established in 2003. Separate Account J is
registered under the Act as a unit investment trust (File No. 811-
21498) and is used to fund variable annuity contracts issued by JNL.
One variable annuity contract funded by Separate Account J is affected
by this application.
Separate Account K was established in 2003. Separate Account K is
registered under the Act as a unit investment trust (File No. 811-
21500) and is used to fund variable annuity contracts issued by JNL.
One variable annuity contract funded by Separate Account K is affected
by this application.
Separate Account L was established in 2000. Separate Account L is
registered under the Act as a unit investment trust (File No. 811-
10271) and is used to fund variable universal life contracts issued by
JNL. One variable universal life contract funded by Separate Account L
is affected by this application (all eleven variable annuity contracts
and the one variable universal life contract affected by this
application are hereinafter collectively referred to as the
``Contracts'').
3. NLVT was organized in Delaware as a statutory trust on November
2, 2005 and is registered under the Act as an open-end management
investment company.
4. Pacific Investment Management Company, LLC (``PIMCO'') is the
investment adviser for the PIMCO Variable Insurance Trust Money Market
Portfolio (the ``Replaced Fund''). PIMCO and the Replaced Fund are not
affiliated with JNL. JNF Advisors, Inc. (``JNF Advisor'') is a recently
formed investment adviser under common control with JNL. JNF Advisor
will serve as investment adviser to the JNF Money Market Portfolio (the
``Replacement Fund''). A I M Advisors, Inc. (``AIM'') will be sub-
adviser for the Replacement Fund. AIM is not affiliated with JNL. There
are no corporate affiliations among the investment advisers.
5. Purchase payments under the Contracts may be allocated to one or
more sub-accounts of the Separate Accounts (the ``Sub-Accounts'').
Income, gains and losses, whether or not realized, from assets
allocated to the Separate Accounts are credited to or charged against
the Separate Accounts without regard to other income, gains or losses
of JNL. The assets maintained in the Separate Accounts will not be
charged with any liabilities arising out of any other business
conducted by JNL. Nevertheless, all obligations arising under the
Contracts, including the commitment to make annuity payments or death
benefit payments, are general corporate obligations of JNL.
Accordingly, all of the assets of JNL are available to meet its
obligations under the Contracts.
6. The Contracts permit allocations of account value to available
Sub-Accounts that invest in specific investment portfolios of
underlying registered investment companies (a ``Fund'' and,
collectively, the ``Mutual Funds''). The Mutual Funds are registered
under the Act as open-end management investment companies.
7. The Contracts permit transfers of accumulation value from one
Sub-Account to another Sub-Account at any time subject to certain
restrictions. No sales charge applies to such a transfer of
accumulation value among Sub-Accounts. A transaction fee is imposed on
purchases or redemptions involving Sub-Accounts (``Transaction Fee Sub-
Accounts'') which invest in certain Funds.\1\ None of the Transaction
Fee Sub-Accounts hold shares of a money market fund.
---------------------------------------------------------------------------
\1\ The Monument Adviser contract (File No. 333-124048) is the
only contract covered by this application that imposes the
transaction fee.
---------------------------------------------------------------------------
8. The Contracts reserve the right, upon notice to contract owners
(the ``Contract Owners''), to substitute shares of another mutual fund
for shares of a Fund held by a Sub-Account.
9. After the Substitution, the investment objective and policies of
the Replacement Fund will be substantially similar to the investment
objective and policies of the Replaced Fund.
10. JNF Advisor will serve as the investment adviser for the
Replacement Fund. However, the management of the Replacement Fund will
be sub-advised by AIM. For the Replaced Fund and the Replacement Fund,
the investment objectives, principal risks, investment adviser/sub-
adviser, and fee structure are shown in the tables that follow. The
tables also show the Replaced Fund's expenses for the fiscal year
ending in 2007 and assets as of December 31, 2007.
11. Substitution 1
------------------------------------------------------------------------
Replaced fund Replacement fund
------------------------------------------------------------------------
Fund Name................... PIMCO Variable JNF Money Market
Insurance Trust Portfolio;
Money Market subadvised by AIM
Portfolio.
Investment Objective........ Seeks maximum Seeks as high a
current income, level of current
consistent with income as is
preservation of consistent with
capital and daily preservation of
liquidity. capital and daily
liquidity.
Strategy.................... Invests at least 95% Invests at least 95%
of its total assets of its total assets
in a diversified in a diversified
portfolio of money portfolio of money
market securities market securities
that are in the that are in the
highest rating highest rating
category for short- category for short-
term obligations. term obligations.
May invest up to 5% May invest up to 5%
of its total assets of its total assets
in money market in money market
securities in the securities in the
second highest second highest
rating category. rating category.
Will only invest in Will only invest in
U.S. dollar U.S. dollar
denominated denominated
securities maturing securities maturing
in 397 days or in 397 days or
less. Dollar- less. Dollar-
weighted average weighted average
portfolio maturity portfolio maturity
will not exceed 90 will not exceed 90
days. days
Principal Risks............. Market Market
Risk. Risk.
Interest Interest
Rate Risk. Rates and Bond
Maturities Risk.
Issuer
Risk. Municipal Bond
Risk.
U.S.
Management Risk. Government
Obligations
Risk.
Inflation--Index Inflation--Index
ed Securities Securities Risk.
Risk.
[[Page 13928]]
Foreign Foreign
(Non-U.S.) Securities Risk.
Investment Risk.
Credit Credit
Risk. Risk.
Significant Principal Risk None
Disparities?.
Adviser/Subadviser.......... PIMCO............... JNF Advisor/ AIM.
Fund Asset Level as of 9/30/ $376,000,000 \(a)\.. $0
07.
Advisory Fee................ 0.15%............... 0.15%
Advisory Fee Schedule....... 0.15% \(b)\......... 0.15% \(b)\
Service Fee................. 0.15%............... 0
12b-1 Fee................... 0................... 0 \(c)\
Other Expenses.............. 0.20%............... 0.51% \(d)\
Total Annual Operating 0.50%............... 0.66%
Expenses.
Fee Reduction............... N/A................. 0.16% \(e)\
Net Total Annual Expenses... 0.50%............... 0.50%
------------------------------------------------------------------------
\(a)\ As of December 31, 2007, approximately 32% of the Replaced Fund's
assets would be transferred to the Replacement Fund.
\(b)\ The advisory fee schedule does not contain breakpoints.
\(c)\ An affirmative vote of shareholders would be required to approve a
Rule 12b-1 plan for the Replacement Fund.
\(d)\ Other fees are based on estimated amounts for the Portfolio's
current fiscal year.
\(e)\ JNF Advisor has contractually agreed to waive its investment
advisory fees and/or reimburse the Money Market Portfolio to the
extent that the ratio of expenses (excluding brokerage fees and
commissions, acquired fund fees and expenses, borrowing costs (such as
interest and dividend expense on securities sold short), taxes and
extraordinary expenses) to net assets on an annual basis exceeds 0.50%
for the Money Market Portfolio. JNF Advisor may discontinue the
contractual limits at any time after April 30, 2009, subject to the
condition in this Application relating to the maximum total operating
expenses for the Replacement Fund for the 24 months following the
Substitution.
The Applicants believe that the Replacement Fund is an appropriate
substitute for the Replaced Fund because the investment objective and
policies of the Replacement Fund are substantially similar to those of
the Replaced Fund. Because the Substitution involves replacing one
money market fund with another money market fund, the Substitution will
not result in a reduced number or a change in the investment
characteristics of the investment options offered under the Contracts.
12. The Substitution will take place at the Funds' relative net
asset values determined on the date of the Substitution in accordance
with Section 22 of the Act and Rule 22c-1 thereunder with no change in
the amount of any Contract Owner's account value or death benefit or in
the dollar value of his or her investment in any of the Sub-Accounts.
Accordingly, there will be no financial impact on any Contract Owner.
13. The Substitution may be effected by having each of the Sub-
Accounts that invests in the Replaced Fund redeem its shares at the net
asset value calculated on the date of the Substitution and purchase
shares of the Replacement Fund at the net asset value calculated on the
same date.
14. In the alternative, should the Replaced Fund determine that a
cash redemption would adversely affect its shareholders, it may redeem
the interest ``in-kind.'' In that case, the Substitution will be
effected by the Sub-Account contributing all the securities it receives
from the Replaced Fund for an amount of Replacement Fund shares equal
to the fair market value of the securities contributed. All in-kind
redemptions from the Replaced Fund of which any of the Applicants is an
affiliated person will be effected in accordance with the conditions
set forth in the Commission's no-action letter issued to Signature
Financial Group, Inc. (available Dec. 28, 1999).
15. The Substitution will be described in a supplement to the
prospectuses for the Contracts (``Supplement'') filed with the
Commission and mailed to Contract Owners. The Supplement will provide
Contract Owners with notice of the Substitution and describe the
reasons for engaging in the Substitution. The Supplement also will
inform Contract Owners with assets allocated to a Sub-Account investing
in the Replaced Fund that the Replaced Fund will not be an available
investment option after the date of the Substitution and that Contract
Owners will have the opportunity to reallocate account value on one day
to one or more Sub-Accounts:
Prior to the Substitution, from the Sub-Accounts investing
in the Replaced Fund, and
For 30 days after the Substitution, from the Sub-Accounts
investing in the Replacement Fund to Sub-Accounts investing in another
Fund available under the respective Contracts,
Without diminishing the number of free transfers that may be made in a
given contract year and without the imposition of any transfer charge
or limitation, other than the transaction fee applicable to certain
Sub-Accounts and any applicable limitations in place to deter
potentially harmful excessive trading.\2\
---------------------------------------------------------------------------
\2\ There are five Transaction Fee Sub-Accounts which are
available only under one annuity contract (File No. 333-124048)
which offers 160 no-fee Sub-Accounts. The Transaction Fee Sub-
Accounts hold shares of the following Nationwide VIT Index Funds:
S&P 500; Small Cap; Mid Cap; International and Bond. These funds
have investment characteristics which are completely unlike those of
the Pimco Variable Insurance Trust Money Market Portfolio which is
being replaced in the Substitution. In light of the foregoing
Applicants do not believe there is any investor protection basis not
to allow the substituted Contract Owners to bear a charge applicable
to all other Contract Owners seeking to invest in a Transaction Fee
Sub-Account.
---------------------------------------------------------------------------
16. The prospectuses for the Contracts will contain the substance
of the information contained in the Supplement concerning the
Substitution. Each Contract Owner will be provided with a prospectus
for the Replacement Fund before the Substitution, unless the
Replacement Fund becomes effective contemporaneously with the
Substitutions, in which case a prospectus will be sent to affected
Contract Owners with the written confirmation. Within five days after
the Substitution, JNL will send affected Contract Owners written
confirmation that the Substitution has occurred and notice that
Contract Owners will have the opportunity to reallocate account value
for 30 days after the Substitution, from the Sub-Accounts investing in
the Replacement Fund to Sub-Accounts investing in another Fund
available under the respective Contracts, without diminishing the
number of free transfers that may be made in a given contract year and
without the imposition of any transfer charge or limitation, other than
the transaction fee applicable to certain Sub-Accounts and any
applicable limitations in place to deter potentially harmful excessive
trading.
[[Page 13929]]
17. JNL will pay all direct and indirect expenses and transaction
costs of the Substitution, including all legal, accounting and
brokerage expenses relating to the Substitution. No costs will be borne
by Contract Owners. Affected Contract Owners will not incur any fees or
charges as a result of the Substitution, nor will their rights or the
obligations of the Applicants under the Contracts be altered in any
way. The Substitution will not cause the fees and charges under the
Contracts currently being paid by Contract Owners to be greater after
the Substitution than before the Substitution. The Substitution will
have no adverse tax consequences to Contract Owners and will in no way
alter the tax benefits to Contract Owners.
18. Applicants believe that their request satisfies the standards
for relief pursuant to Section 26(c) of the Act, as set forth below,
because the affected Contract Owners will have:
(1) Account values allocated to a Sub-Account invested in the
Replacement Fund with an investment objective and policies
substantially similar to the investment objective and policies of the
Replaced Fund; and
(2) The Replacement Fund whose current total annual expenses will
be no higher than that of the Replaced Fund for its 2007 fiscal year
because, as described below, JNL has agreed to, for a period of 24
months following the Substitutions, limit the total net expenses of the
Replacement Fund to those of the Replaced Fund for the 2007 fiscal
year. At the end of the 24 month period it is possible that the
expenses of the Replacement Fund may be higher.
Applicants' and Section 17 Applicants' Legal Analysis
1. The Applicants represent that Section 26(c) of the Act makes it
unlawful for any depositor or trustee of a registered unit investment
trust holding the security of a single issuer to substitute another
security for such security unless the Commission approves the
substitution. The Commission will approve such a substitution if the
evidence establishes that it is consistent with the protection of
investors and the purposes fairly intended by the policy and provisions
of the Act.
2. The Applicants note that the purpose of Section 26(c) is to
protect the expectation of investors in a unit investment trust that
the unit investment trust will accumulate shares of a particular issuer
by preventing unscrutinized substitutions that might, in effect, force
shareholders dissatisfied with the substituted security to redeem their
shares, thereby possibly incurring either a loss of the sales load
deducted from initial premium payments, an additional sales load upon
reinvestment of the redemption proceeds, or both. Moreover, in the
insurance product context, a Contract Owner forced to redeem may suffer
adverse tax consequences. Section 26(c) affords this protection to
investors by preventing a depositor or trustee of a unit investment
trust that holds shares of one issuer from substituting for those
shares the shares of another issuer, unless the Commission approves
that substitution.
3. The Applicants assert that the purposes, terms and conditions of
the Substitution are consistent with the principles and purposes of
Section 26(c) and do not entail any of the abuses that Section 26(c) is
designed to prevent. Applicants have reserved the right to make such a
substitution under the Contracts and this reserved right is disclosed
in the prospectus for the Contracts.
4. The Applicants submit that the investment objectives and
policies of the Replacement Fund are sufficiently similar to those of
the Replaced Fund that Contract Owners will have continuity in
investment expectations. Accordingly, the Replacement Fund is an
appropriate investment vehicle for those Contract Owners who have
account values allocated to the Replaced Fund.
5. The Applicants represent that for the 24-month period following
the date of the Substitution, JNL agrees to limit the total operating
expenses of the Replacement Fund (taking into account any expense
waiver or reimbursement) on an annualized basis to the net expense
level of the Replaced Fund for the 2007 fiscal year. In addition, for
24 months following the Substitution, JNL will not increase asset-based
fees or charges for Contracts outstanding on the day of the
Substitution. JNL represents that the Substitution and the selection of
the Replacement Fund were not motivated by any financial consideration
paid or to be paid by the Replacement Fund, its adviser. its sub-
adviser or underwriters, or their respective affiliates.\3\
---------------------------------------------------------------------------
\3\ In this regard, JNL has been receiving .30% annually in
``revenue sharing'' with respect to investments by its separate
accounts in the Replaced Fund and expects that it will receive that
same percentage amount from the Replacement Fund. With respect to
the Replaced Fund, JNL receives .15% pursuant to the Replaced Fund's
Administrative Services Plan and .15% from the Replaced Fund's
investment adviser for non-marketing services rendered to current
and prospective Contract Owners. With respect to the Replacement
Fund, JNL expects to receive from the Replacement Fund .30% for
administrative services.
---------------------------------------------------------------------------
6. The Applicants assert that the Substitution will not result in
the type of costly forced redemption that Section 26(c) was intended to
guard against and, for the following reasons, is consistent with the
protection of investors and the purposes fairly intended by the Act:
(1) The Replacement Fund is an appropriate fund to which to move
Contract Owners with account values allocated to the Replaced Fund
because the new fund has substantially similar investment objectives
and policies.
(2) The costs of the Substitution, including any brokerage costs,
will be borne by JNL and will not be borne by Contract Owners. No
charges will be assessed to effect the Substitution.
(3) The Substitution will be at the net asset value of the shares
without the imposition of any transfer or similar charge and with no
change in the amount of any Contract Owner's account value.
(4) The Substitution will not cause the fees and charges under the
Contracts currently being paid by Contract Owners to be greater after
the Substitution than before the Substitution and will result in
Contract Owners' account values being moved to a Fund with the same or
lower current total annual expenses.
(5) All Contract Owners will be given notice of the Substitution
prior to the Substitution and will have an opportunity before, and for
30 days after, the Substitution to reallocate account value among other
available Sub-Accounts without diminishing the number of free transfers
that may be made in a given contract year and without the imposition of
any transfer charge or limitation, other than the transaction fee
applicable to certain Sub-Accounts and any applicable limitations in
place to deter potentially harmful excessive trading or limitation on
the number of transfers to or from the fixed accounts available with
the variable annuity contracts.
(6) Within five days after the Substitution, JNL will send to its
affected Contract Owners written confirmation that the Substitution has
occurred.
(7) The Substitution will in no way alter the insurance benefits to
Contract Owners or the contractual obligations of JNL.
(8) The Substitution will have no adverse tax consequences to
Contract Owners and will in no way alter the tax benefits to Contract
Owners.
(9) The Replacement Fund will not rely on any ``manager of
managers''
[[Page 13930]]
exemptive relief unless such action is approved by a majority of the
Replacement Fund's shareholders at a meeting whose record date is after
the Substitution has been effected.
7. The Section 17 Applicants request an order under Section 17(b)
exempting them from the provisions of Section 17(a) to the extent
necessary to permit JNL to carry out the proposed substitution. Section
17(a)(1) of the Act, in relevant part, prohibits any affiliated person
of a registered investment company, or any affiliated person of such
person, acting as principal, from knowingly selling any security or
other property to that company. Section 17(a)(2) of the Act generally
prohibits the persons described above, acting as principal, from
knowingly purchasing any security or other property from the registered
company.
8. JNL, as depositor of the Separate Accounts, is an affiliate of
the Separate Accounts and also JNF Advisor, which serves as investment
adviser for the affected NLVT series. As such, JNF Advisor could be
deemed to control the affected NLVT series and be an affiliate of the
affected NLVT series. Assuming, for this or other reasons, that an
affected NLVT series is an affiliate of an affiliate of JNL, to the
extent the Separate Accounts each use assets received in-kind to
purchase Replacement Fund Shares, the substitutions would involve one
or more purchases or sales of securities or property between persons
who are affiliates of affiliates. Accordingly, the Section 17
Applicants are seeking relief, to the extent necessary, from Section
17(a) for the in-kind purchases and sales of Replacement Fund Shares.
9. Section 17(b) of the Act provides that the Commission may, upon
application, grant an order exempting any transaction from the
prohibitions of Section 17(a) if the evidence establishes that:
(1) The terms of the proposed transaction, including the
consideration to be paid or received, are reasonable and fair and do
not involve overreaching on the part of any person concerned;
(2) The proposed transaction is consistent with the policy of each
registered investment company concerned, as recited in its registration
statement and records filed under the Act; and
(3) The proposed transaction is consistent with the general
purposes of the Act.
10. The Section 17 Applicants submit that, for all the reasons set
forth in paragraphs 3-6 immediately above, the terms of the proposed
in-kind purchases of shares of the Replacement Fund by the Separate
Accounts, including the consideration to be paid and received, as
described in this Application, are reasonable and fair and do not
involve overreaching on the part of any person concerned. The Section
17 Applicants also submit that the proposed in-kind purchases by the
Separate Accounts are consistent with the policies of JNL and the
affected NLVT series. Finally, the Section 17 Applicants submit that
the proposed substitutions are consistent with the general purposes of
the Act.
11. The Section 17 Applicants assert that, to the extent the
Separate Account's in-kind purchases of Replacement Fund shares are
deemed to involve principal transactions between entities which are
affiliates of affiliates, the procedures described below should be
sufficient to assure that the terms of the proposed transactions are
reasonable and fair to all participants. The Section 17 Applicants
maintain that the terms of the proposed in-kind purchase transactions,
including the consideration to be paid and received by each Fund
involved, are reasonable, fair and do not involve overreaching. In
addition, although not applicable, the in-kind transactions will
conform with all except one of the conditions enumerated in Rule 17a-7.
The proposed transactions will take place at relative net asset value
in conformity with the requirements of Section 22(c) of the Act and
Rule 22c-1 thereunder with no change in the amount of any Contract
Owner's account value or death benefit or in the dollar value of his or
her investment in any Sub-Account. Contract Owners will not suffer any
adverse tax consequences as a result of the substitution. The fees and
charges under the Contracts will not increase because of the
substitution. Even though they may not rely on Rule 17a-7, the Section
17 Applicants believe that the Rule's conditions outline the type of
safeguards that result in transactions that are fair and reasonable to
registered investment company participants and preclude overreaching.
12. The Section 17 Applicants will carry out the proposed in-kind
purchases in conformity with all of the conditions of Rule 17a-7 and
the Replacement Fund's procedures thereunder, except that the
consideration paid for the securities being purchased or sold may not
be entirely cash. Nevertheless, the circumstances surrounding the
proposed substitution will be such as to offer the same degree of
protection to the Replacement Fund from overreaching that Rule 17a-7
provides to them generally in connection with their purchase and sale
of securities under that Rule in the ordinary course of their business.
In particular, JNL (or any of their affiliates) cannot effect the
proposed transaction at a price that is disadvantageous to the
Replacement Fund. Although the transaction may not be entirely for
cash, it will be effected based upon (1) the independent market price
of the portfolio securities valued as specified in paragraph (b) of
Rule 17a-7, and (2) the net asset value per share of the Fund valued in
accordance with the procedures disclosed in its registration statement
and as required by Rule 22c-1 under the Act. No brokerage commission,
fee, or other remuneration will be paid to any party in connection with
the proposed in-kind transaction.
13. The Section 17 Applicants assert that the sale of shares of the
Replacement Fund for investment securities, as contemplated by the
proposed in-kind transaction, is consistent with the investment policy
and restrictions of the Replacement Fund because (1) the shares are
sold at their net asset value, and (2) the portfolio securities are of
the type and quality that the Replacement Fund would each have acquired
with the proceeds from share sales had the shares been sold for cash.
To assure that the second of these conditions is met, the sub-adviser
will examine the portfolio securities being offered to the Replacement
Fund and accept only those securities as consideration for shares that
it would have acquired for such fund in a cash transaction.
14. The Section 17 Applicants submit that the proposed in-kind
transactions are consistent with the general purposes of the Act as
stated in the Findings and Declaration of Policy in Section 1 of the
Act. The proposed transactions do not present any of the conditions or
abuses that the Act was designed to prevent. In particular, Sections
1(b)(2) and (3) of the Act state, among other things, that the national
public interest and the interest of investors are adversely affected
``when investment companies are organized, operated, managed, or their
portfolio securities are selected in the interest of directors,
officers, investment advisers, depositors, or other affiliated persons
thereof, or in the interests of other investment companies or persons
engaged in other lines of business, rather than in the interest of all
classes of such companies' security holders; * * * when investment
companies issue securities containing inequitable or discriminatory
provisions, or fail to protect the preferences and privileges of the
holders of their outstanding
[[Page 13931]]
securities * * *.'' For all the reasons stated in Sections V.B. and VI
of the Application, the abuses described in Sections l(b)(2) and (3) of
the Act will not occur in connection with the proposed in-kind
purchases.
15. The Section 17 Applicants note that the Commission has
previously granted exemptions from Section 17(a) in circumstances
substantially similar in all material respects to those presented in
this Application to applicants affiliated with an open-end management
investment company that proposed to purchase shares issued by the
company with investment securities of the type that the company might
otherwise have purchased for its portfolio. In these cases, the
Commission issued an order pursuant to Section 17(b) of the Act where
the expense of liquidating such investment securities and using the
cash proceeds to purchase shares of the investment company would have
reduced the value of investors' ultimate investment in such shares.
Conclusion
For the reasons and upon the facts set forth above, the Applicants
and the Section 17 Applicants believe that the requested order meets
the standards set forth in Section 26(c) and Section 17(b),
respectively, and should, therefore, be granted.
For the Commission, by the Division of Investment Management,
under delegated authority.
Florence E. Harmon,
Deputy Secretary.
[FR Doc. E8-5100 Filed 3-13-08; 8:45 am]
BILLING CODE 8011-01-P